Seer (SEER) EPS (Weighted Average and Diluted) (2020 - 2026)
Seer (SEER) recorded quarterly EPS (Weighted Average and Diluted) of -$0.3 in Q1 2026, down 3.45% quarter-over-quarter from -$0.29 in Q4 2025, and up 11.76% on a YoY basis from -$0.27 in Q1 2025.
Seer (SEER) EPS (Weighted Average and Diluted) (2020 - 2026) Analysis & Trends
Seer's EPS (Weighted Average and Diluted) history runs 7 years deep, the most recent figure standing at -$0.3 for Q1 2026.
- In Q1 2026, EPS (Weighted Average and Diluted) rose 11.76% year-over-year to -$0.3; the TTM figure through Mar 2026 stood at -$1.24 (up 12.06% YoY), while the FY2025 annual figure was -$1.28, up 7.91% from the prior year.
- EPS (Weighted Average and Diluted) was -$0.3 for Q1 2026 at Seer, down from -$0.29 in the prior quarter.
- In the past five years, EPS (Weighted Average and Diluted) ranged from a high of -$0.28 in Q4 2023 to a low of -$0.38 in Q1 2022.
- Historically, EPS (Weighted Average and Diluted) has averaged -$0.34 across 5 years, with a median of -$0.35 in 2024.
- The sharpest annual moves came in 2022 and 2023: EPS (Weighted Average and Diluted) slumped 40.74% in 2022, then grew 22.22% in 2023.
- A 5-year view of EPS (Weighted Average and Diluted) shows it stood at -$0.36 in 2022, then gained by 22.22% to -$0.28 in 2023, then tumbled by 32.14% to -$0.37 in 2024, then increased by 21.62% to -$0.29 in 2025, then decreased by 3.45% to -$0.3 in 2026.
- The last three EPS (Weighted Average and Diluted) figures came in at -$0.3 (Q1 2026), -$0.29 (Q4 2025), and -$0.32 (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Weighted Avg. Diluted) (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 719,706.53 Bn | 719,706.50 Bn | - | - |
| 2 | Belite Bio | 55,800.00 Bn | 55,800.00 Bn | - | 0.68 |
| 3 | Quantum Biopharma | 18,182.30 Bn | 18,182.29 Bn | - | 3.06 |
| 4 | Legend Biotech | 3,154.00 Bn | 3,153.71 Bn | 242.10 Mn | 3,086.42 |
| 5 | Akari Therapeutics | 1,844.30 Bn | 1,844.29 Bn | - | 0.00 |
| 6 | Evaxion A | 1,567.96 Bn | 1,567.94 Bn | - | - |
| 7 | Psyence Biomedical | 251.43 Bn | 251.42 Bn | - | 0.00 |
| 8 | Vertex Pharmaceuticals | 112.56 Bn | 105.31 Bn | 2.59 Bn | 4.02 |
| 9 | Abivax | 94.37 Bn | 94.37 Bn | - | -0.61 |
| 10 | Seer | 99.67 Mn | 99.67 Mn | 982,000.00 | -0.30 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -0.30 |
| Dec 31, 2025 | -0.29 |
| Sep 30, 2025 | -0.32 |
| Jun 30, 2025 | -0.33 |
| Mar 31, 2025 | -0.34 |
| Dec 31, 2024 | -0.37 |
| Sep 30, 2024 | -0.35 |
| Jun 30, 2024 | -0.35 |
| Mar 31, 2024 | -0.32 |
| Dec 31, 2023 | -0.28 |
| Sep 30, 2023 | -0.33 |
| Jun 30, 2023 | -0.37 |
| Mar 31, 2023 | -0.38 |
| Dec 31, 2022 | -0.36 |
| Sep 30, 2022 | -0.38 |
| Jun 30, 2022 | -0.37 |
| Mar 31, 2022 | -0.38 |
| Dec 31, 2021 | -0.32 |
| Sep 30, 2021 | -0.30 |
| Jun 30, 2021 | -0.27 |